Novartis
Associate Director, ADC platform in Oncology Drug Discovery
- Location
- Cambridge (USA), MA (MA)
- Posted
- Posted today (employer shows the date only)
- Source
- Workday (employer's applicant tracking system)
- Category
- R&D/Science
- Industry
- Pharma/Biotech
Application: Workday — account required, long form — you fill it in on the employer's site.
UNTIL never charges to apply and never asks for payment or personal info on behalf of employers.
Apply kitYour saved details, ready to copy
From the employer's posting
Job Description Summary
#LI-Onsite
Location: Cambridge, MA, USA
About the Role
We are expanding our ADC group at Novartis and are seeking an accomplished Associate Director to join our discovery team and lead scientific strategy in ADC payloads, linker technologies, and conjugation approaches. This role will be central to advancing differentiated ADC and related targeted therapeutic programs by integrating deep payload expertise, linker/conjugation knowledge, and biology-driven mechanism-of-action insights.
The ideal candidate will have deep cancer biology expertise and bring extensive industry experience in ADC discovery or development, with a strong track record of applying payload, linker, and conjugation expertise to therapeutic program strategy. This individual will work closely with cross-functional teams to help drive next-generation ADC concepts.
Job Description
Key Responsibilities:
- Lead scientific strategy for ADC payload selection, linker design, conjugation approaches, and related platform innovations
- Apply deep knowledge of payload classes, mechanisms of action, potency, resistance biology, bystander activity, and tolerability considerations to guide program design
- Partner with chemistry, biology, protein engineering, pharmacology, translational sciences, and CMC teams to advance next gen ADCs
- Evaluate and prioritize novel payloads, linkers, and conjugation technologies for internal programs and external opportunities
- Provide biology-driven insights into payload mechanism of action, tumor context, therapeutic index, and combination opportunities
- Guide experimental strategies to assess ADC activity, selectivity, resistance mechanisms, linker stability, and payload-related pharmacology
- Contribute to next-generation ADC platform strategy, including differentiated payload-linker concepts and biology-matched ADC design
- Represent payload/linker biology expertise in project teams, governance discussions, and external collaborations
- Monitor scientific, clinical, competitive, and IP landscapes related to ADC payloads, linkers, conjugation technologies, and emerging modalities
- Mentor junior scientists and contribute to a collaborative, high-performing scientific culture
Essential Requirements:
- Ph.D. in cancer biology, pharmacology, chemical biology, biochemistry, medicinal chemistry, bioengineering, or related discipline
- 5–10 years of relevant industry experience in ADC discovery, targeted therapeutics, oncology drug discovery, or related areas
- Deep expertise in cancer biology, signaling pathways, cancer dependencies and cell death mechanisms
- Demonstrated understanding of ADC biology, tumor targeting, internalization, trafficking, payload release, bystander effects, and pharmacology
- Proven ability to integrate biology, chemistry, and translational data into actionable ADC program strategies
- Experience leading cross-functional scientific discussions and influencing program direction
- Strong communication, leadership, and collaboration skills
Preferred Experience:
- Direct experience advancing ADC programs from discovery through lead optimization, candidate selection, or early development
- Experience with specific ADC payload classes and emerging payload modalities
- Familiarity with linker-payload optimization, DAR considerations, conjugation chemistry, and ADC analytical characterization
- Experience evaluating external technologies, partnerships, licensing opportunities, or competitive landscapes
- Understanding of translational biomarkers, patient selection, clinical resistance mechanisms, or clinical ADC data
- Track record of scientific leadership through publications, patents, presentations, program advancement, or external engagement
Key Attributes:
- Recognized subject-matter expert in ADC payloads, linker biology, and conjugation strategy
- Strategic thinker who can connect payload mechanism, tumor biology, and ADC design
- Strong cross-functional leader with the ability to influence without direct authority
- Scientifically rigorous, collaborative, and highly proactive
- Comfortable operating across discovery, translational, and early development interfaces
- Passionate about developing differentiated ADC therapies for patients
Novartis Compensation and Benefit Summary:
The salary for this position is expected to range between $145,600-$270,400 USD Annual per year.
The final salary offered is determined based on factors like, but not limited to, relevant skills and experience, and upon joining Novartis will be reviewed periodically. Novartis may change the published salary range based on company and market factors.
Your compensation will include a performance-based cash incentive and, depending on the level of the role, eligibility to be considered for annual equity awards.
US-based eligible employees will receive a comprehensive benefits package that includes health, life and disability benefits, a 401(k) with company contribution and match, and a variety of other benefits. …
Similar live roles
- Principal Scientist I/II for Multi-specific biologics in Oncology Drug Discovery
Novartis · Posted todayCambridge (USA), MA - Principal Scientist II
Novartis · Posted todayCambridge (USA), MA - Clinical Laboratory Technician - Core Lab
Labcorp · Posted yesterdayHolyoke MA - Director, Central Laboratory Operations
Takeda · Posted yesterdayMassachusetts - Virtual - Director, Clinical Pharmacology
Takeda · Posted yesterdayUSA - MA - Cambridge - Kendall Square - 500 - Oncology Discovery BioSciences Intern
Bristol Myers Squibb · Posted yesterdayCambridge Crossing - MA - US